How is the Acelrx Pharmaceuticals Inc today?

The Acelrx Pharmaceuticals Inc today is trading in the down by 0.00% at 0.49.

What is Acelrx Pharmaceuticals Inc Annual Revenue?

Acelrx Pharmaceuticals Inc Annual Revenue fell 37.15%, in the last year to $1.77 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Acelrx Pharmaceuticals Inc Annual Net Profit?

Acelrx Pharmaceuticals Inc Annual Net Profit rose 236.06% in the last year to $47.76 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Acelrx Pharmaceuticals Inc Price to Earning Ratio?

Acelrx Pharmaceuticals Inc Price to Earning Ratio is -0.39, which is negative.

What is Acelrx Pharmaceuticals Inc Stock Price?

Acelrx Pharmaceuticals Inc Stock Price fell 2% and underperformed its sector by 57.47% in the past year.

What is Acelrx Pharmaceuticals Inc Quarterly Net profit?

Acelrx Pharmaceuticals Inc Quarterly Net profit rose 79.9% YoY to $1.36 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Acelrx Pharmaceuticals Inc Debt to Equity Ratio?

Acelrx Pharmaceuticals Inc Debt to Equity Ratio of 0.48 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Acelrx Pharmaceuticals Inc Mutual Fund Holding?

Acelrx Pharmaceuticals Inc Mutual Fund Holding increased by 2.37% in the last quarter to 2.76.

What is Acelrx Pharmaceuticals Inc Promoter Share Holding?

Acelrx Pharmaceuticals Inc Promoter Share Holding stayed the same in the most recent quarter at 0.12%.

What is Acelrx Pharmaceuticals Inc Interest Coverage Ratio?

Acelrx Pharmaceuticals Inc Interest Coverage Ratio is 42.43, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Acelrx Pharmaceuticals Inc Institutional Holding?

Acelrx Pharmaceuticals Inc Institutional Holding increased by 6.46% in the last quarter to 15.01.

Acelrx Pharmaceuticals Inc XNAS: ACRX

Acelrx Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Acelrx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acelrx Pharmaceuticals Inc
Rating: 1.43383325
Author: Trendlyne DVM scores

about

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamos...

0.49 0.00 (0.00%)

New 52W Low today

21,607 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

26.3 / 100

Technically Bearish

31.0 / 100

No estimates available

Acelrx Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acelrx Pharmaceuticals Inc FAQ

How is Acelrx Pharmaceuticals Inc today?

Acelrx Pharmaceuticals Inc today is trading in the red, and is down by 0.00% at 0.49.

How has Acelrx Pharmaceuticals Inc performed historically?

Acelrx Pharmaceuticals Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -3.92%. stock has been down -2.00% in the past quarter and fell -2.00% in the past year. You can view this in the overview section.